TRANSFORM

Device Stryker Corporation
Total Payments
$46,061
Transactions
96
Doctors
55
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $472.70 24 21
2023 $100.52 8 8
2022 $32,034 32 16
2021 $2,850 19 13
2020 $50.65 3 3
2019 $55.42 1 1
2018 $10,499 9 7

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $27,261 1 59.2%
Consulting Fee $16,431 7 35.7%
Food and Beverage $1,873 86 4.1%
Travel and Lodging $496.18 2 1.1%

Payments by Type

Research
$27,261
1 transactions
General
$18,800
95 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
THE CITADEL EMBOLIZATION DEVICE FEASIBILITY STUDY Stryker Corporation $27,261 0

Top Doctors Receiving Payments for TRANSFORM — Page 3

Doctor Specialty Location Total Records
, M.D Specialist Englewood, CO $6.65 1
, M.D Diagnostic Radiology Englewood, CO $6.65 1
, M.D Diagnostic Radiology Englewood, CO $6.65 1
, D.O Diagnostic Radiology Englewood, CO $6.65 1
, M.D Neurology Tucson, AZ $6.57 1
, M.D Neurology Saint Louis, MO $6.29 1

About TRANSFORM

TRANSFORM is a device associated with $46,061 in payments to 55 healthcare providers, recorded across 96 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.

Payment data is available from 2018 to 2024. In 2024, $472.70 was paid across 24 transactions to 21 doctors.

The most common payment nature for TRANSFORM is "Unspecified" ($27,261, 59.2% of total).

TRANSFORM is associated with 1 research study, including "THE CITADEL EMBOLIZATION DEVICE FEASIBILITY STUDY" ($27,261).